Efficacy and safety of Vitamin D for type 2 diabetes mellitus: a systematic review

National Medical Journal of China

Volumn 93, Issue 18, 2013, Pages 1401-1406

  Gao, Wei ^a   Chen, Da Wei ^a   Liu, Guan Jian ^b   Ran, Xing Wu ^a  

^a SICHUAN UNIVERSITY   (China)

^b NONE

Author keywords

Diabetes mellitus, type 2; Meta analysis; Randomized controlled trials; Systematic review; Vitamin D

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; VITAMIN D;

CLINICAL ASSESSMENT TOOL; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HOMEOSTASIS MODEL ASSESSMENT HOMEOSTASIS MODEL ASSESSMENT; HUMAN; HYPERCALCEMIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; HUMANS; INSULIN RESISTANCE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; VITAMIN D;

EID: 84879137561     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2013.18.009     Document Type: Review

References (30)

1. Wild S, Roglic G, Green A, et al. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care, 2004, 27:1047-1053.
2. Macdonald H M, Mavroeidi A, Barr R J, et al. Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone, 2008, 42: 996-1003.
3. Holick M F. High prevalence of vitamin D inadequacy and implication for health. Mayo Clin Proc, 2006, 81:353-373.
4. Holick M F. Vitamin D deficiency. N Engl J Med, 2007, 357: 266-281.
5. Bischoff-Ferrari H A, Giovannucci E, Willett W C, et al. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr, 2006, 84:18-28.
6. Mathieu C, Gysemans C, Giulietti A, et al. Vitamin D and diabetes. Diabetologia, 2005, 48:1247-1257.
7. 3 prevents insulitis in NOD mice. Diabetes, 1992, 41:1491-1495.
8. Liu S, Song Y, Ford E S, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older U. S. women. Diabetes Care, 2005, 28:2926-2932.
9. Pittas A G, Dawson-Hughes B, Li T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care, 2006, 29:650-656.
10. Nikooyeh B, Neyestani T R, Farvid M, et al. Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am J Clin Nutr, 2011, 93: 764-771.
11. Wareham N J, Byrne C D, Carr C, et al. Glucose intolerance is associated with altered calcium homeostasis: a possible link between increased serum calcium concentration and cardiovascular disease mortality. Metabolism, 1997, 46: 1171-1177.
12. Grimnes G, Emaus N, Joakimsen R M, et al. Baseline serum 25-hydroxyvitamin D concentrations in the Tromsø Study 1994-95 and risk of developing type 2 diabetes mellitus during 11 years of follow-up. Diabet Med, 2010, 27: 1107-1115.
13. Robinson J G, Manson J E, Larson J, et al. Lack of association between 25 (OH) D levels and incident type 2 diabetes in older women. Diabetes Care, 2011, 34:628-634.
14. de Boer I H, Tinker L F, Connelly S, et al. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative. Diabetes Care, 2008, 31:701-707.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care, 2008, 31:S55-S60.
16. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. Cochrane Handbook for Systematic Reviews of Interventions Version 5. 1. 0 (updated March 2011). http://www.cochrane-handbook.org.
17. Jorde R, Figenschau Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr, 2009, 48:349-354.
18. Witham M D, Dove F J, Dryburgh M, et al. The effect of different doses of vitamin D (3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia, 2010, 53:2112-2119.
19. Patel P, Poretsky L, Liao E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: a pilot prospective randomized trial. J Diabetes, 2010, 2: 36-40.
20. Shab-Bidar S, Neyestani T R, Djazayery A, et al. Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial. BMC Med, 2011, 24: 125.
21. Eftekhari M H, Akbarzadeh M, Dabbaghmanesh M H, et al. Impact of treatment with oral calcitriol on glucose indices in type 2 diabetes mellitus patients. Asia Pac J Clin Nutr, 2011, 20:521-526.
22. Woerle H J, Neumann C, Zschau S, et al. Impact of fasting and postprandial glycemia on overall glycemic control in type 2 diabetes Importance of postprandial glycemia to achieve target HbA1c levels. Diabetes Res Clin Pract, 2007, 77:280-285.
23. Mitri J, Muraru M D, Pittas A G. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr, 2011, 65: 1005-1015.
24. Pittas A G, Lau J, Hu F B, et al. The role of vitamin D and calcium in type 2 diabetes. A systematic review and metaanalysis. J Clin Endocrinol Metab, 2007, 92:2017-2029.
25. Speer G, Cseh K, Winkler G, et al. Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity. Eur J Endocrinol, 2001, 144: 385-389.
26. Milner R D, Hales C N. The role of calcium and magnesium in insulin secretion from rabbit pancreas studied in vitro. Diabetologia, 1967, 3:47-49.
27. Draznin B, Sussman K, Kao M, et al. The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes. J Biol Chem, 1987, 262: 14385-14388.
28. Maestro B, Campion J, Davila N, et al. Stimulation by 1, 25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J, 2000, 47:383-391.
29. Giulietti A, van Etten E, Overbergh L, et al. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1, 25-Dihydroxyvitamin D (3) works as anti-inflammatory. Diabetes Res Clin Pract, 2007, 77:47-57.
30. Gregori S, Giarratana N, Smiroldo S, et al. A 1alpha, 25-dihydroxyvitamin D (3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes, 2002, 51: 1367-1374.